Nihon Kohden (OTCMKTS:NHNKY) Hits New 1-Year Low – What’s Next?

Nihon Kohden Corporation (OTCMKTS:NHNKY) shares reached a new 52-week low on Thursday . The stock traded as low as $8.87 and last traded at $9.41, with a volume of 8254 shares traded. The stock had previously closed at $9.04.

Analysts Set New Price Targets

Several equities research analysts have issued reports on NHNKY shares. UBS Group raised shares of Nihon Kohden from a “hold” rating to a “strong-buy” rating in a research note on Monday, January 19th. Zacks Research upgraded Nihon Kohden to a “hold” rating in a report on Monday, April 27th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy”.

Nihon Kohden Price Performance

The firm has a 50 day moving average of $9.48 and a two-hundred day moving average of $10.55. The stock has a market cap of $1.52 billion, a PE ratio of 17.43 and a beta of 0.41.

Nihon Kohden (OTCMKTS:NHNKY) last announced its earnings results on Thursday, May 14th. The company reported $0.34 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.10. Nihon Kohden had a net margin of 5.32% and a return on equity of 7.25%. As a group, equities analysts anticipate that Nihon Kohden Corporation will post 0.48 EPS for the current fiscal year.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.